Trastuzumab Active Not Recruiting Phase 2 Trials for Esophageal Cancers / Malignant Neoplasm of Stomach Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01191697CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer